FDA Clears Personalized Brain Stimulation Treatment for PTSD with 68% Remission Rate in Clinical Trial

A new personalized brain stimulation treatment for Post-Traumatic Stress Disorder (PTSD), developed by California-based Wave Neuroscience in collaboration with Texas A&M University, has received FDA clearance. Early clinical trial findings reported a 52% reduction in PTSD symptoms and a 68% remission rate, offering a promising drug-free alternative for patients who have not found sufficient relief from existing treatments.